Espace presse

CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration

25/01/2024

Identification of a new genetic disease responsible for pulmonary alveolar proteinosis and mycobacterial infections

24/01/2024

A new genetic disease linked to the X chromosome explains immunity problems in the face of mycobacteria

07/11/2023

Sanofi, WhiteLab Genomics, the TaRGeT Laboratory at Nantes University, and Institut Imagine launch WIDGeT to make France a global leader in gene therapy.

24/10/2023

« Escape Genes », the first educational Escape Game on genetics, is back at the Institut Imagine!

20/10/2023

Launch of the Sharing Fund "Invest for Childhood": When private equity serves the common good

03/07/2023

MEDETIA, in partnership with Institut Imagine and Inserm Transfert, launches an innovative research program with Ipsen

06/06/2023

Isabelle André, Director of Research at Institut Imagine, joins the French Ministry of Higher Education, Research and Innovation as Scientific Director for the Health-Biology sector

01/06/2023

Accelerating gene therapy: assessment and prospects at the end of the DIM Gene Therapy program

24/01/2023

A new gene therapy strategy for sickle cell disease and beta thalassemia

22/11/2022

CNX France creates engaging, positive and inspiring media for Institut Imagine

10/11/2022

Institut Imagine, Hôpital Necker-Enfants malades AP-HP and HELEBOR collaborate in a clinical and fundamental research partnership on children's pain

18/10/2022

Institut Imagine and SimforHealth announce a partnership in rare genetic diseases to support the training of healthcare professionals through digital simulation

13/10/2022

More than 8 million euros raised for research into genetic diseases at an exceptional charity auction

13/09/2022

Scientists discover novel mutation associated with alternating hemiplegia of childhood

12/07/2022